{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:12:06Z","timestamp":1792102326596,"version":"4.4.0"},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>For therapies for Alzheimer's disease (AD) to have the greatest impact, it will likely be necessary to treat individuals in the \u201cpreclinical\u201d (presymptomatic) stage. Fluid and neuroimaging measures are being explored as possible biomarkers of AD pathology that could aid in identifying individuals in this stage to target them for clinical trials and to direct and monitor therapy. The objective of this study was to determine whether cerebrospinal fluid (CSF) biomarkers for AD suggest the presence of brain damage in the preclinical stage of AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We investigated the relation between structural neuroimaging measures (whole\u2010brain volume) and levels of CSF amyloid\u2010\u03b2 (A\u03b2)\n                      <jats:sub>40<\/jats:sub>\n                      , A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , tau, and phosphorylated tau\n                      <jats:sub>181<\/jats:sub>\n                      (ptau\n                      <jats:sub>181<\/jats:sub>\n                      ), and plasma A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      and A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      in well\u2010characterized research subjects with very mild and mild dementia of the Alzheimer type (n = 29) and age\u2010matched, cognitively normal control subjects (n = 69).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Levels of CSF tau and ptau\n                      <jats:sub>181<\/jats:sub>\n                      , but not A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , correlated inversely with whole\u2010brain volume in very mild and mild dementia of the Alzheimer type, whereas levels of CSF A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , but not tau or ptau\n                      <jats:sub>181<\/jats:sub>\n                      , were positively correlated with whole\u2010brain volume in nondemented control subjects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>\n                      Reduction in CSF A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , likely reflecting A\u03b2 aggregation in the brain, is associated with brain atrophy in the preclinical phase of AD. This suggests that there is toxicity associated with A\u03b2 aggregation before the onset of clinically detectable disease. Increases in CSF tau (and ptau\n                      <jats:sub>181<\/jats:sub>\n                      ) are later events that correlate with further structural damage and occur with clinical onset and progression. Ann Neurol 2009;65:176\u2013183\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ana.21559","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T08:23:34Z","timestamp":1236068614000},"page":"176-183","source":"Crossref","is-referenced-by-count":272,"title":["Decreased cerebrospinal fluid A\u03b2\n                    <sub>42<\/sub>\n                    correlates with brain atrophy in cognitively normal elderly"],"prefix":"10.1002","volume":"65","author":[{"given":"Anne M.","family":"Fagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.9.1395"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1385\/JMN:17:2:101"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199812000-00009"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.1.38"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.1.2.196"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/78981552"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.16.2094"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00530-1"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440108"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380413"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20730"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.3.298"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380414"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199712220-00022"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl269"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm136"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240105"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.3.326"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2412-a"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000228231.26111.6e"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque\u2010associated changes in amyloid\u2010b metabolism and half\u2010life","volume":"23","author":"Cirrito J","year":"2003","journal-title":"J Neurosci"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.1880010509"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2004.06.018"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhh174"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154530.72969.11"},{"key":"e_1_2_6_29_2","volume-title":"Co\u2010planar stereotaxic atlas of the human brain","author":"Talairach J","year":"1988"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1109\/42.906424"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.10062"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00569-X"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009"},{"key":"e_1_2_6_34_2","volume-title":"Applied multiple regression\/correlations analysis for the behavioral sciences","author":"Cohen J","year":"2003"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.3.noc60123"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.5.750"},{"key":"e_1_2_6_37_2","first-page":"76","article-title":"Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria","volume":"7","author":"Nagy Z","year":"1996","journal-title":"Dementia"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000079053.77227.14"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21223"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000115115.98960.37"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20889"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.07.003"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.5.770"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)01483-0"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(03)00197-5"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.11.018"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000313"},{"key":"e_1_2_6_49_2","unstructured":"DickersonB BakkourA SalatD et al.The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid\u2010positive individuals. Cereb Cortex2008Jul 16 [Epub ahead of print]"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2003.12.005"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000267428.62582.aa"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70355-6"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.21559","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.21559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:04:42Z","timestamp":1697436282000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.21559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1002\/ana.21559"],"URL":"https:\/\/doi.org\/10.1002\/ana.21559","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1158720.618938","asserted-by":"object"}]},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}